renal cell carcinoma: the emulsion and checkmate 214 trials
Published 6 years ago • 118 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
2:30
checkmate 214 trial update
-
1:54
checkmate 214 trial in rcc updates
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:02
key rcc data: javelin renal 101 & checkmate 214
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer
-
4:13
checkmate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma
-
1:06
dr. agarwal on the checkmate-214 trial for kidney cancer
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
1:06
dr. mckay discusses the checkmate-214 trial in rcc
-
4:23
first-line therapy options for rcc: lessons from checkmate 214 and keynote-427
-
1:32
dr. pal compares checkmate-214 and cabosun trials in rcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
5:06
phase 3 checkmate - 214
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
5:12
renal cell carcinoma trial analysis: current landscape of immunotherapy combinations
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
-
1:37
dr. amin on rationale for checkmate-214 trial in rcc
-
1:49
bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
13:10
asco gu24 special: prof. nizar tannir shares checkmate 214 results